(Q52646820)

English

Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.

scientific article published on 18 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

0 references

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Francesco Di Raimondo

6

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Gian Matteo Rigolin

9

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Giorgina Specchia

18

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Francesca Romana Mauro

38

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Pier Luigi Zinzani

23

object named as

Pier Luigi Zinzani

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

object named as

Silvia Soriani

27

0 references

object named as

Rita Rizzi

17

0 references

Massimo Massaia

object named as

Massimo Massaia

14

0 references

Agostino Cortelezzi

object named as

Agostino Cortelezzi

10

0 references

Giovanni Del Poeta

object named as

Giovanni Del Poeta

4

0 references

object named as

Livio Trentin

16

0 references

1

object named as

Robin Foà

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

15

object named as

Stefano Molica

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Vincenzo Callea

12

object named as

Vincenzo Callea

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Maura Brugiatelli

13

object named as

Maura Brugiatelli

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

3

object named as

Antonio Cuneo

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Stefania Ciolli

5

object named as

Stefania Ciolli

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Alfonso Piciocchi

34

object named as

Alfonso Piciocchi

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Irene Della Starza

33

object named as

Irene Della Starza

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Marilisa Marinelli

31

object named as

Marilisa Marinelli

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Sabina Chiaretti

39

object named as

Sabina Chiaretti

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Ilaria Del Giudice

2

object named as

Ilaria Del Giudice

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

40

object named as

Anna Guarini

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Achille Ambrosetti

21

object named as

Achille Ambrosetti

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Fortunato Morabito

25

object named as

Fortunato Morabito

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

28

object named as

Nadia Peragine

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Simona Tavolaro

29

object named as

Simona Tavolaro

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

30

object named as

Silvia Bonina

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Maria Stefania De Propris

32

object named as

Maria Stefania De Propris

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

author name string

Francesco Lauria

7

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Emanuele Cencini

8

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Francesco Nobile

11

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Francesca Di Serio

19

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Lorella Orsucci

20

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Marco Montillo

22

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Felicetto Ferrara

24

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Maria Angela Mura

26

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Alessandra Alietti

35

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Eva Josephine Runggaldier

36

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Enrica Gamba

37

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

publication date

18 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

American Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

89

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

5

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

480-486

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Conventional dose fludarabine-based regimens are effective but have excessive toxicity in elderly patients with refractory chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Chlorambucil--still not bad: a reappraisal

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Clinical significance of CD38 expression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Employment of oligodeoxynucleotide plus interleukin-2 improves cytogenetic analysis in splenic marginal zone lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Chronic lymphocytic leukemia in less fit patients: "slow-go".

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Treatment of elderly patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23668

21 January 2018

Identifiers

10.1002/AJH.23668

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 May 2018

http://europepmc.org/abstract/MED/24415640

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52646820&oldid=1846274550"